BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32978027)

  • 21. Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR).
    Dhaliwal I; Kassirian S; Mitchell MA; Qiabi M; Warner A; Louie AV; Wong HH; McDonald CM; Rajchgot J; Palma DA
    BMC Cancer; 2022 Apr; 22(1):468. PubMed ID: 35484614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of follow-up care after curative radiotherapy ± chemotherapy for stage I-III non-small cell lung cancer.
    Mohan S; Beydoun N; Nasser E; Nguyen A; Shafiq J; Vinod S
    Asia Pac J Clin Oncol; 2019 Jun; 15(3):172-180. PubMed ID: 30761737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancer.
    Kilburn JM; Lester SC; Lucas JT; Soike MH; Blackstock AW; Kearns WT; Hinson WH; Miller AA; Petty WJ; Munley MT; Urbanic JJ
    J Thorac Oncol; 2014 Apr; 9(4):572-6. PubMed ID: 24736084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A decade of community-based outcomes of patients treated with curative radiotherapy with or without chemotherapy for non-small cell lung cancer.
    Pramana A; Descallar J; Vinod SK
    Asia Pac J Clin Oncol; 2016 Sep; 12(3):e357-66. PubMed ID: 25155757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.
    Sibley GS; Jamieson TA; Marks LB; Anscher MS; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):149-54. PubMed ID: 9422571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).
    Rowell NP; Williams CJ
    Cochrane Database Syst Rev; 2001; (2):CD002935. PubMed ID: 11406051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).
    Rowell NP; Williams CJ
    Cochrane Database Syst Rev; 2001; (1):CD002935. PubMed ID: 11279780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.
    Sun B; Brooks ED; Komaki RU; Liao Z; Jeter MD; McAleer MF; Allen PK; Balter PA; Welsh JD; O'Reilly MS; Gomez D; Hahn SM; Roth JA; Mehran RJ; Heymach JV; Chang JY
    Cancer; 2017 Aug; 123(16):3031-3039. PubMed ID: 28346656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer.
    Brooks ED; Sun B; Feng L; Verma V; Zhao L; Gomez DR; Liao Z; Jeter M; O'Reilly M; Welsh JW; Nguyen QN; Erasmus JJ; Eapen G; Ahrar K; Antonoff MB; Hahn SM; Heymach JV; Rice DC; Chang JY
    JAMA Netw Open; 2018 Aug; 1(4):e181390. PubMed ID: 30646121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic endoscopic staging of mediastinum to determine impact on radiotherapy for locally advanced lung cancer (SEISMIC): protocol for a prospective single arm multicentre interventional study.
    Steinfort DP; Siva S; Rangamuwa K; Lee P; Fielding D; Nguyen P; Jennings BR; Yo S; Hardcastle N; Kothari G; Crombag L; Annema J; Yasufuku K; Ost DE; Irving LB
    BMC Pulm Med; 2022 Sep; 22(1):364. PubMed ID: 36153502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer.
    Ostheimer C; Bache M; Güttler A; Reese T; Vordermark D
    BMC Cancer; 2014 Nov; 14():858. PubMed ID: 25416631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation.
    Dieleman E; van der Woude L; van Os R; van Bockel L; Coremans I; van Es C; De Jaeger K; Knol HP; Kolff W; Koppe F; Pomp J; Reymen B; Schinagl D; Spoelstra F; Tissing-Tan C; van der Voort van Zyp N; van der Wel A; Wijsman R; Dielwart M; Wiegman E; Damhuis R; Belderbos J
    Clin Lung Cancer; 2023 Mar; 24(2):130-136. PubMed ID: 36572596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non small cell carcinoma of the lung. A retrospective study. Presented at the 41st annual meeting of the Royal Australasian College of Radiologists, September 1990, Perth.
    Stevens G; Firth I
    Australas Radiol; 1992 Aug; 36(3):243-8. PubMed ID: 1280099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contact of a tumour with the pleura is not associated with regional recurrence following stereotactic ablative radiotherapy for early stage non-small cell lung cancer.
    Wink KCJ; Löck S; Rossi M; van Baardwijk A; Belderbos J; de Ruysscher D; Troost EGC
    Radiother Oncol; 2019 Feb; 131():120-126. PubMed ID: 30773178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new index comparable to BED for evaluating the biological efficacy of hypofractionated radiotherapy schemes on early stage non-small cell lung cancer: analysis of data from the literature.
    Kong C; Guo WJ; Zha WW; Zhu XZ; Huang SF; Zhang YW; Xu JH; He X
    Lung Cancer; 2014 Apr; 84(1):7-12. PubMed ID: 24548340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Early Death in Patients with Early-Stage NSCLC-Can We Select Patients without a Potential Benefit of SBRT as a Curative Treatment Approach?
    Klement RJ; Belderbos J; Grills I; Werner-Wasik M; Hope A; Giuliani M; Ye H; Sonke JJ; Peulen H; Guckenberger M
    J Thorac Oncol; 2016 Jul; 11(7):1132-9. PubMed ID: 27060654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic Ablative Body Radiotherapy Versus Radical Radiotherapy: Comparing Real-World Outcomes in Stage I Lung Cancer.
    Phillips I; Sandhu S; Lüchtenborg M; Harden S
    Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):681-687. PubMed ID: 31377081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction Models for Mediastinal Metastasis and Its Detection by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in Potentially Operable Non-Small Cell Lung Cancer: A Prospective Study.
    Chung HS; Yoon HI; Hwangbo B; Park EY; Choi CM; Park YS; Lee K; Ji W; Park S; Lee GK; Kim TS; Kim HY; Kim MS; Lee JM
    Chest; 2023 Sep; 164(3):770-784. PubMed ID: 37019355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung.
    Gauden S; Ramsay J; Tripcony L
    Chest; 1995 Nov; 108(5):1278-82. PubMed ID: 7587429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.